Healthcare

Targeted and personalized therapeutics are likely to transform the existing precision medicine landscape. With recent landmark regulatory approval, CAR T therapy has the potential to emerge as the industry standard for cancer management in the future and potentially replace existing treatment techniques. Bispecific and multi-specific antibody plat...

Predictive biomarkers are used to provide the best treatment indication with the greater probability of response to a certain specific chemotherapeutic agent, also considering treatment-related side effects. Prognostic biomarkers are used to identify patients with different clinical outcomes associated with somatic mutations, alterations in DNA met...

Patient engagement is crucial to better clinical outcomes and a high-performing health system. Patient engagement improves communication between the patients and their care providers, resulting in timely access to healthcare, reduces hospital re-admissions, and enables efficient management of illness. This research service showcases the different t...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

Clinical trials are slow and expensive process. Over the years, especially last year, the number of drugs approved through successful clinical trials has reduced significantly. Due to several clinical trial failures, pharmaceutical companies have suffered significant revenue loss. Based on Frost and Sullivan’s research, integration of digital tec...

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the syn...

Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witn...

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Edit...

TechVision's Medical Devices and Imaging technology cluster's flagship research service profiles ten cutting-edge medical technologies that are expected to have a huge impact on the healthcare industry in the next two years. Each of technologies that have been profiled here represent billions of dollars in market potential, and have a rich track re...